News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,279 Results
Type
Article (144)
Company Profile (1)
Press Release (1134)
Section
Business (446)
Career Advice (19)
Deals (49)
Drug Development (221)
FDA (46)
Job Trends (17)
News (777)
Policy (107)
Tag
Alliances (36)
Approvals (45)
Best Places to Work (10)
Career advice (13)
Clinical research (192)
COVID-19 (1)
Data (2)
Diagnostics (4)
Drug pricing (1)
Earnings (204)
Events (254)
Executive appointments (4)
FDA (47)
GLP-1 (1)
Government (19)
Healthcare (19)
Infectious disease (1)
Inflation Reduction Act (1)
Interviews (5)
IPO (20)
Job creations (7)
Job search strategy (11)
Layoffs (1)
Legal (18)
Medical device (2)
Medtech (2)
Mergers & acquisitions (31)
Neuroscience (3)
NextGen: Class of 2026 (7)
Non-profit (3)
Opinion (3)
People (190)
Phase 1 (48)
Phase 2 (62)
Phase 3 (88)
Pipeline (5)
Policy (1)
Postmarket research (29)
Preclinical (10)
Radiopharmaceuticals (1)
Real estate (7)
Regulatory (80)
Research institute (1)
Resumes & cover letters (4)
Special edition (1)
Spinal muscular atrophy (1)
Startups (12)
The Weekly (1)
Date
Last 365 days (23)
2026 (3)
2025 (22)
2024 (36)
2023 (73)
2022 (80)
2021 (94)
2020 (104)
2019 (85)
2018 (78)
2017 (56)
2016 (62)
2015 (62)
2014 (55)
2013 (44)
2012 (58)
2011 (74)
2010 (56)
Location
Africa (2)
Arizona (1)
Asia (13)
Australia (1)
California (2)
Europe (512)
Georgia (1)
Massachusetts (13)
New Jersey (1)
North Carolina (1)
South America (1)
Southern California (2)
United States (18)
1,279 Results for "alkermes".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuroscience
Alkermes Pushes Narcolepsy Program to Phase III With ‘Highly Competitive’ Mid-Stage Data
Alixorexton’s Phase II performance sets it up for late-stage success, according to analysts at Truist Securities. Alkermes expects to launch a global late-stage program early next year for narcolepsy type 2.
November 13, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Alkermes’ up to $2.1B Purchase of Avadel Sets Groundwork for ‘Strategic Evolution’
With Avadel under its fold, Alkermes expects to accelerate its expansion into the sleep market, laying the foundation for its late-stage narcolepsy asset alixorexton.
October 23, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 30, 2025
·
1 min read
Press Releases
Alkermes to Participate in Two Upcoming December 2025 Investor Conferences
November 26, 2025
·
1 min read
Mergers & acquisitions
UPDATE: Avadel Accepts Alkermes’ Revised $2.37B Counteroffer, Besting Lundbeck
Lundbeck had tried to scoop the narcolepsy drug maker out from under Alkeremes with $2.4 billion, but Avadel has elected to go with its original suitor.
November 19, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Alkermes Announces Positive Topline Results From Vibrance-2 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 2
November 13, 2025
·
11 min read
Neuroscience
Alkermes One Ups Takeda in Narcolepsy, Clearing Cognitive Impairments in Mid-Stage Trial
Presenting at the World Sleep Congress 2025, the Dublin-based company’s Phase II study bested Takeda drug in both efficacy and safety.
September 8, 2025
·
2 min read
·
Dan Samorodnitsky
Mergers & acquisitions
Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel
A day after Pfizer closed its hotly contested Metsera deal, Lundbeck has made an unsolicited offer to steal Avadel Pharmaceuticals away from Alkermes.
November 14, 2025
·
1 min read
·
Annalee Armstrong
Alkermes to Participate in Two Upcoming June 2024 Investor Conferences
Alkermes plc announced that management will participate in fireside chat presentations at two upcoming investor conferences.
May 29, 2024
·
1 min read
Business
Alkermes plc Reports First Quarter 2024 Financial Results
Alkermes plc reported financial results for the first quarter of 2024.
May 1, 2024
·
14 min read
1 of 128
Next
